SEARCH

SEARCH BY CITATION

References

  • Aka E, Legris C, Tanimoto T, Matsushita R & Kimura K (2005) Counterfeit medicine detection by authenticity investigation: a pilot study in the street market of Côte d’Ivoire. Japanese Society of Social Pharmacy 24, 716.
  • Aldhous P (2005) Counterfeit pharmaceuticals: murder by medicine. Nature 434, 132136.
  • Amin AA & Kokwaro GO (2007) Antimalarial drug quality in Africa. Journal of Clinical Pharmacy and Therapeutics 32, 429440.
  • Hanif M, Mobarak MR, Ronan A, Rahman D, Donovan JJ Jr & Bennish ML (1995) Fatal renal failure caused by diethylene glycol in paracetamol elixir: the Bangladesh epidemic. British Medical Journal 311, 8891.
  • IMPACT (2007) Principles and Elements for National Legislation against Counterfeit Medical products: Text Endorsed by IMPACT General Meeting; International Medical Products Anti-Counterfeiting Taskforce, Lisbon, http://www.who.int/impact/events/FinalPrinciplesforLegislation.pdf. Accessed 12 December 2007.
  • Kaur H, Goodman C, Thompson E et al. (2008) A nationwide survey of the quality of antimalarials in retail outlets in Tanzania. PLoS ONE 3, e3403.
  • Kelesidis T, Kelesidis I, Rafailidis PI & Falagas ME (2007) Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence. Journal of Antimicrobial Chemotherapy 60, 214236.
  • Khan AY & Ghilzai NMK (2007) Counterfeit and substandard quality of drugs: the need for an effective and stringent regulatory control in India and other developing countries. Indian Journal of Pharmacology 39, 206207.
  • Lee KJ, Bae YT, Kim DH et al. (2002) Status of intestinal parasites infection among primary school children in Kampongcham, Cambodia. Korean Journal of Parasitology 40, 153156.
  • Lon CT, Tsuyuoka R, Phanouvong S et al. (2006) Counterfeit and substandard antimalarial drugs in Cambodia. Transactions of the Royal Society of Tropical Medicine and Hygiene 100, 10191024.
  • MOH (2001) Study Report on Counterfeit and Substandard Drugs in Cambodia 2001. Ministry of Health, Phnom Penh.
  • MOH (2004) 2nd Study Report on Counterfeit and Substandard Drugs in Cambodia 2004. Ministry of Health, Phnom Penh.
  • MOH (2005) Pharmaceutical Sector Strategic Plan 2005–2010. Department of Drugs and Food, Ministry of Health, Phnom Penh.
  • MOH (2006a) Drug Quality Assurance: TLC Project Report – Cambodia. Department of Drugs and Food, Phnom Penh.
  • MOH (2006b) Essential Medicine List. The Committee for Establishing the National Essential Medicine List, Ministry of Health, Phnom Penh.
  • MOH (2006c) Good Pharmacy Practice (GPP) in Cambodia. Department of Drugs and Food, Ministry of Health, Phnom Penh.
  • MOH (2009) Statistic of Pharmacies, Depot and Illegal Drug Stores in December, 2008. Ministry of Health, Pnom Penh.
  • Newton PN, Green MD, Fernández FM, Day NP & White NJ (2006) Counterfeit anti-infective drugs. The Lancet Infectious Diseases 6, 602613.
  • Onwujekwe O, Kaur H, Dike N et al. (2009) Quality of anti-malarial drugs provided by public and private healthcare providers in south-east Nigeria. Malaria Journal 8, 22.
  • Parak SK, Kim D-H, Deung Y-K et al. (2004) Status of intestinal parasite infections among children in Bat Dambang, Cambodia. Korean Journal of Parasitology 42, 201203.
  • Stich AHR, Biays S, Odermatt P et al. (1999) Distribution of infection and morbidity in northern Cambodia. Tropical Medicine & International Health 4, 674685.
  • Sulaiman SM, Traore M, Engels D, Hagan P & Cioli D (2001) Counterfeit praziquantel. Lancet 358, 666667.
  • Surendran A (2004) World agencies try to stem flood of fake drugs. Nature Medicine 10, 111.
  • Taylor RB, Shakoor O, Behrens RH et al. (2001) Pharmacopoeial quality of drugs supplied by Nigerian pharmacies. Lancet 357, 19331936.
  • USP (2005) The United States Pharmacopeia 28. vol NF 23, The United States Pharmacopeial Convention, Washington, D.C.
  • Vuong TA, Nguyen TT, Klank LT, Phung DC & Dalsgaard A (2007) Faecal and protozoan parasite contamination of water spinach (Ipomoea aquatica)cultivated in urban wastewater in Phnom Penh, Cambodia. Tropical Medicine & International Health 12, 7381.
  • White N (1999) Antimalarial drug resistance and combination chemotherapy. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 354, 739749.
  • WHO (1999) Counterfeit Drugs: Guidelines for the development of measures to combat counterfeit drugs (WHO/EDM/QSM/99.1). WHO, Geneva. http://whqlibdoc.who.int/hq/1999/WHO_EDM_QSM_99.1.pdf
  • WHO (2007) Western Pacific Country Health Information Profiles: 2007 Edition. WHO, Manila.
  • WHO (2009a) General Information on Counterfeit Medicines. WHO, Geneva. http://www.who.int/medicines/services/counterfeit/overview/en/ Accessed May 27 2009.
  • WHO (2009b) What are Substandard Drugs? WHO, Geneva. http://www.who.int/medicines/services/counterfeit/faqs/06/en/index.html Accessed July 15 2009.
  • Yanagisawa S, Mey V & Wakai S (2004) Comparison of health-seeking behaviour between poor and better-off people after health sector reform in Cambodia. Public Health 118, 2130.
  • Yang D, Plianbangchang P, Visavarungroj N & Rujivipat S (2004) Quality of pharmaceutical items available from drugstores in Phnom Penh, Cambodia. Southeast Asian Journal of Tropical Medicine and Public Health 35, 741747.